Notice2021-17535
Request for Information: Comments on the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Draft Strategic Plan
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 17, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
This Request for Information (RFI) is intended to seek feedback from the public on the draft National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Strategic Plan for Research. NIDDK invites input from: The scientific research community; patients and caregivers; health care providers and health advocacy organizations; scientific and professional organizations; federal agencies; and other stakeholders, including interested members of the public. Organizations are strongly encouraged to submit a single response that reflects the views of their organization and their membership as a whole.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 156 (Tuesday, August 17, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 156 (Tuesday, August 17, 2021)]
[Notices]
[Pages 46000-46001]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-17535]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information: Comments on the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK) Draft Strategic Plan
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Request for Information (RFI) is intended to seek
feedback from the public on the draft National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK) Strategic Plan for Research.
NIDDK invites input from: The scientific research community; patients
and caregivers; health care providers and health advocacy
organizations; scientific and
[[Page 46001]]
professional organizations; federal agencies; and other stakeholders,
including interested members of the public. Organizations are strongly
encouraged to submit a single response that reflects the views of their
organization and their membership as a whole.
DATES: Comments must be received by 11:59:59 p.m. (ET) on August 31,
2021 to ensure consideration.
ADDRESSES: All comments must be submitted electronically on the
submission website, available at <a href="https://rfi.grants.nih.gov/?s=60fef9beab43000053007ed2">https://rfi.grants.nih.gov/?s=60fef9beab43000053007ed2</a>.
FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to: Lisa
Gansheroff, <a href="/cdn-cgi/l/email-protection#f6b8bfb2b2bd858284978293919f95869a9798b6989f9ed8919980"><span class="__cf_email__" data-cfemail="6826212c2c231b1c1a091c0d0f010b1804090628060100460f071e">[email protected]</span></a>, 301-496-6623.
SUPPLEMENTARY INFORMATION: This Notice is in accordance with the 21st
Century Cures Act, NIH institutes are required to regularly update
their strategic plans. The NIDDK's ongoing Institute-wide strategic
planning process will develop a broad vision for accelerating research
into the causes, prevention, and treatment of diseases and conditions
within the Institute's mission. This overarching trans-NIDDK Strategic
Plan will complement NIDDK's disease-specific planning efforts. The
Strategic Plan will have a 5-year time horizon but will also include
planning for longer term efforts that could be initiated within this
time frame.
External input has been integral to the strategic planning process.
NIDDK established a Working Group of Council, comprised of 44 external
scientists and patient advocates, including a subset of the members of
NIDDK's Advisory Council and others with expertise across the range of
NIDDK's mission areas. The Institute also invited broad external input
with a public RFI in 2020, and received valuable comments from
organizations, individual researchers, people living with diseases in
NIDDK's mission, and others. Based on input from the Working Group, the
previous RFI, and Council, the Institute has prepared a draft of the
Strategic Plan; the draft will be available for public comment through
August 31, 2021 via the new RFI at the link above.
NIDDK is committed to empowering a multidisciplinary research
community; engaging diverse stakeholders; and leveraging discoveries of
connections among diseases across NIDDK's mission to improve
prevention, treatment, and health equity--pursuing pathways to health
for all. This theme is addressed throughout the draft strategic plan.
The draft Strategic Plan includes five major sections:
<bullet> Advance understanding of biological pathways and
environmental contributors to health and disease
<bullet> Advance pivotal clinical studies and trials for
prevention, treatment, and cures in diverse populations
<bullet> Advance research to disseminate and implement evidence-
based prevention strategies and treatments in clinics and community
settings, to improve the health of all people, more rapidly and more
effectively
<bullet> Advance stakeholder engagement--including patients and
other participants as true partners in research
<bullet> Promote efficient and effective ways to serve as a trusted
steward of public resources and support research for diseases across
our mission
NIDDK invites comments on the draft Strategic Plan from: The
scientific research community; patients and caregivers; health care
providers and health advocacy organizations; scientific and
professional organizations; federal agencies; and other stakeholders,
including interested members of the public. Organizations are strongly
encouraged to submit a single response that reflects the views of their
organization and membership as a whole.
Responses to this RFI are voluntary and may be submitted
anonymously. Please do not include any information that you do not wish
to make public. Proprietary, classified, confidential, or sensitive
information should not be included in your response. The Government
will use the information submitted in response to this RFI at its
discretion. Individual feedback will not be provided to any responder.
The Government reserves the right to use any submitted information on
public websites, in reports, in summaries of the state of the science,
in any possible resultant solicitation(s), grant(s), or cooperative
agreement(s), or in the development of future funding opportunity
announcements. This RFI is for informational and planning purposes only
and is not a solicitation for applications or an obligation on the part
of the Government to provide support for any ideas identified in
response to it. Please note that the Government will not pay for the
preparation of any information submitted or for use of that
information. NIDDK looks forward to your input and we hope that you
will share this RFI with your colleagues.
Dated: August 11, 2021.
Bruce Tibor Roberts,
Health Science Policy Analyst, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2021-17535 Filed 8-16-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 17, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.